[Antibodies to cell culture cells as an interference factor in chlamydia serology]

Area of Science:

• Immunology
• Microbiology
• Rheumatology

Context:

• Rheumatic diseases encompass a range of autoimmune and inflammatory conditions affecting joints, muscles, and connective tissues.
• Chlamydia trachomatis is a common bacterial pathogen, primarily known for causing sexually transmitted infections and trachoma.
• The potential role of microbial infections in triggering or exacerbating autoimmune diseases is an area of ongoing research.

Purpose:

• To investigate the presence of antibodies against Chlamydia trachomatis in patients with rheumatic diseases.
• To determine the correlation between Chlamydia trachomatis antibodies and anticellular antibodies in this patient cohort.

Summary:

• Antibodies against Chlamydia trachomatis were detected using an immunoperoxidase assay (IPA) in 32 patients with rheumatic diseases.
• The study utilized Chlamydia trachomatis serotype L2-infected cells as antigen for IPA.
• Additionally, sera were tested for anticellular antibodies using non-infected cells as antigen, revealing that 13 of the 32 IPA-positive patients (41%) also tested positive for anticellular antibodies.

Impact:

• This research highlights a potential association between Chlamydia trachomatis infection and the presence of anticellular antibodies in individuals with rheumatic diseases.
• Findings may contribute to understanding the role of infectious agents in the pathogenesis of rheumatic conditions.
• Further investigation into Chlamydia trachomatis as a potential trigger for autoimmune responses in rheumatology is warranted.